Wockhardt Launches SEBI-Mandated Special Window for Physical Share Transfer Re-lodgment

Wockhardt Limited initiated a special window on April 18, 2026, for shareholders to re-lodge requests for transferring physical shares, complying with a Securities and Exchange Board of India (SEBI) mandate. This move addresses the transfer of paper share certificates, aligning with broader regulatory efforts for market transparency.

On April 18, 2026, Wockhardt Limited, an Indian pharmaceutical company, opened a special window for re-lodging physical share transfer requests, adhering to new regulatory requirements.

This action follows a mandate from the Securities and Exchange Board of India (SEBI), India's market regulator, aiming to streamline the process for shareholders holding paper share certificates rather than electronic dematerialized shares.

The SEBI circular, issued on January 30, 2026, compelled listed companies to establish such windows, ensuring a defined mechanism for shareholders whose transfer requests were previously returned or rejected.

The company officially communicated this initiative through a newspaper advertisement, making the announcement public.

Rashmi Mamtura, Company Secretary for Wockhardt Ltd., digitally signed and authorized the disclosure on April 18, 2026, confirming the company's compliance at 18:41:31 IST.

The special window allows shareholders to resubmit transfer requests for shares held in physical form that were previously not processed. This regulatory step aims to minimize discrepancies and improve data accuracy in share ownership records.

Wockhardt (NSE: WOCKHARDT), trading on the National Stock Exchange of India, saw its stock price move +0.05% on the day of the announcement. Over the past five trading days, the company's shares gained +3.88%, and +17.44% over the last month. However, the stock experienced a -1.26% decline over the past year, contrasting with a +230.90% increase over the last five years, indicating longer-term growth despite recent fluctuations.

SEBI's mandate signals a continued push towards greater digitization of shareholdings within India's financial markets. Investors will observe how other companies in the pharmaceutical sector and broader market respond to these re-lodgment requirements.